Slide 1: BIOLASE Technology, Inc.
BIOLASE Technology, Inc.Federico Pignatelli, CEO, Chairman and Shareholder The Leading Growth Company Focused Investment Bank for 26 Years
Slide 2: Safe Harbor Statement
Safe Harbor Statement This presentation may contain forward-looking statements that are based on our current expectations, estimates and projections about our industry as well as management's beliefs and assumptions. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "e
Slide 3: Redefining Surgery in Dentistry and Medicine
Redefining Surgery in Dentistry and Medicine 4/5/2011 PAGE 3 Conventional Surgical Devices: Scalpel, High Speed Drill, Electrosurge, Electric Bone Saws and Heat Generating LasersHow BIOLASE Changes That?The Science of WaterLase Years of engineering and research at BIOLASE led to the discovery that t
Slide 4: Why BIOLASE WaterLase Technology in Dentistry?
Why BIOLASE WaterLase Technology in Dentistry? 4/5/2011 PAGE 4
Slide 5: Traditional Dentistry
Traditional Dentistry Traditional Dentistry 4/5/2011 PAGE 5
Slide 6: Progressive & Biological Hi-Tech Dentistry
4/5/2011 PAGE 6 Progressive & Biological Hi-Tech Dentistry Atraumatic Pediatric Tooth Extraction The aiming beam on the NEW WaterLase iPlus is green. This red beam featured in the previous generation of WaterLase products does not cut the tissue. Tissue is cut biologically, with water at the molecul
Slide 7: Making Dentistry Less Frightening
Making Dentistry Less Frightening 4/5/2011 PAGE 7 Traditional Surgical Approach: Using the dental drill offers more of the same which is pain, local anesthetic, swelling, pain killers, micro-fractures and potential cross contamination. Progressive and Hi-tech Surgical Approach: Using WaterLase techn
Slide 8: Technology Supported by Scientific Data
Technology Supported by Scientific Data 4/5/2011 PAGE 8 Substantial Data: The effectiveness of dental lasers is proven and well researched. Clinical data and peer- reviewed specialty journals substantiate the effectiveness of laser treatment in a wide variety of procedures.
Slide 9: Dental Schools Teaching WaterLase Technology Around the World
Some of the Dental Schools that are Teaching WaterLase Technology around the World 4/5/2011 PAGE 9
Slide 10: WaterLase High Speed Cutting
WaterLase High Speed Cutting 4/5/2011 PAGE 10
Slide 11: Why WaterLase: No Pain, No Tissue Damage, No Cross-Contamination
Why WaterLase Technology: Because NO Pain, NO Tissue Damage & NO Risk of Cross- Contamination 4/5/2011 PAGE 12 WaterLase MD(tm) reduced E. faecalis 2.86 times more effectively than NaOCl3 1. Dental Burs and Endodontic Files: Are Routine Sterilization Procedures Effective?: Archie Morrison, DDS, MS,
Slide 12: Foundation for a Rapid Recovery
Foundation for a Rapid Recovery Why a turnaround of BIOLASE today will be quicker and more effective than in the past:BIOLASE has a better organizational structure, better cost control, and more efficient & effective management than ever before.The BIOLASE brand is currently known by over 80% of Nor
Slide 13: How BIOLASE is Positioned
How BIOLASE is Positioned 7,300 4,500 2,600 1,600 Total: 11,800 Total: 4,200 Grand Total: 16,000 4/5/2011 PAGE 14 BIOLASE North America BIOLASE International
Slide 14: Owning the Hard Tissue Dental Laser Market
Owning BIOLASE Means Owning the Hard Tissue Dental Laser Market... Biolase80% Source: Biolase Technology Licensing Reports 4/5/2011 PAGE 15
Slide 15: Share of the Overall Dental Laser Market
....and of the overall dental laser market. Biolase45% Source: iData Research Inc. 4/5/2011 PAGE 16 2009 US Dental Laser Market: Hard & Soft Tissue
Slide 16: Our Market Opportunity
Our Market Opportunity 176,000 dentists in the US and Canada.1Over 1.2 million dentists in 134 countries.216,000 systems in 10,000 practices.Every 1% of further market penetration is equal to an opportunity of well over $600 million, including consumables. (CHART) 16,0003 systems sold worldwide 1,20
Slide 17: The Untapped Portion of the Market
The Untapped Portion of the Market According to the ADA...nearly 25% of all Americans avoid dentists because they are afraid of dental drills and needles.There are 160,000 dentists currently serving a population of 300 million Americans.That means 75 million Americans are avoiding dental care becaus
Slide 18: Global Opportunity in Emerging Dental Markets
Global Opportunity in Emerging Dental Markets North America176,000 dentists1 dentist / 1,900 population Western Europe240,000 dentists1 dentist / 1,800 population Latin America298,000 dentists1 dentist / 5,600 population Eastern Europe120,000 dentists1 dentist / 4,000 population Middle East19,000 de
Slide 19: Emerging Market Opportunities
Emerging Market Opportunities 4/5/2011 PAGE 20 Private Dental Office in China California Suburb? No...China
Slide 20: The Value of Technology
The Value of Technology 4/5/2011 PAGE 21 Dental Lasers: Allows dentists to perform their current daily procedures more efficiently plus perform a wide variety of dental procedures they otherwise may be referring out of their practices.Cone Beam 3-D Dental Imaging: Provides a high-definition, digital
Slide 21: Expanding into Other Areas of Medicine
Expanding into Other Areas of Medicine 4/5/2011 PAGE 22 Ophthalmology: BIOLASE currently holds 10 issued and 19 pending U.S. and International patents in four patent families in the field ophthalmology. These patents give BIOLASE a wide range of applications and coverage in the field. Management is
Slide 22: Current Line of BIOLASE Products
Current Line of BIOLASE Products 4/5/2011 PAGE 23 All-tissue dental lasers: Our all-tissue lasers include our new flagship laser, the revolutionary WaterLase iPlus and the WaterLase MD Turbo, an entry level all-tissue laser.Diode soft-tissue dental lasers: Our soft tissue lasers include the ezLase t
Slide 23: BIOLASE Technology, Inc. Today
BIOLASE Technology, Inc. Today Global leader in dental lasersOver 16,000 laser systems sold to over 10,000 dental practices in over 50 countries worldwide.We have over 160 employees worldwideWe have sales offices in the US, Floss (Germany), Madrid (Spain) and Shanghai (China) with expansion planned
Slide 24: Operations: Manufacturing and Research & Development
Operations Manufacturing and Research & Development Our 57,000 sq. ft. facility houses administrative, sales, marketing, customer care, R&D and manufacturing. It is ISO 9001 certified and FDA GMP with clean room operations. Nearly 100% of our components and subassemblies are manufactured in our faci
Slide 25: Management & Employee Stakeholders
Management & Employee Stakeholders Management and Employees: BIOLASES's entire executive team holds options to purchase common stock. Further, in December 2010, the Board of Directors granted approximately 1.5 million stock options to ALL of the employees of the Company. These options have a strike
Slide 26: Chart & Financial History
4/5/2011 PAGE 27 Volume: Millions of Shares 0.5 1.0 Chart & Financial History 20 15 10 5 BLTISHAREPRICE Guidance 62.5 1994-2006 Pignatelli Chairman of the Board Exclusive distribution partnership with Henry Schein Aug 2006-Aug 2010 Aug 2010-Present Pignatelli CEO & Board Chairman 1998 FDA Clearance
Slide 27: Relative Valuations
Relative Valuations Relative Valuations
Slide 28: BIOLASE Technology, Inc.
The Leading Growth Company Focused Investment Bank for 26 Years BIOLASE Technology, Inc.